Cross-border execution. Long-term partnership.
We invest in exceptional global founders building category-defining companies across vertical AI, physical AI and robotics, AI infrastructure, and deep tech.
WHO WE ARE
Treeo VC is a U.S.-based venture capital firm partnering with ambitious global founders from pre-seed through seed to build enduring technology companies.
We believe the most compelling opportunities emerge where technological breakthroughs meet fundamental industry challenges. Our conviction rests on exceptional teams’ ability to turn complex innovation into commercially scalable businesses.
Ecosystem Statement
Our strength lies in connecting founders with the people, capital, and industry expertise needed to accelerate growth across markets.
LP Integration
We create opportunities for our LPs to engage with emerging technologies, innovative companies, and the broader U.S. venture ecosystem, extending the value of the partnership beyond capital.
THE CROSS-BORDER ADVANTAGE
Borderless Thinking
Technical Edge
Connected Capital
Enterprise Access
We help founders translate global ambition into disciplined U.S. execution, creating companies capable of competing on the world stage.
HOW WE INVEST
We are guided by
three core principles
Investing
ahead of
the curve.
State of the art tools for computational biology
Provides a scalable platform and API that enables scientists to run advanced computational biology tools without managing infrastructure. Researchers can perform tasks such as protein structure prediction, antibody engineering, and molecular docking through a streamlined interface that automates computation and orchestration. By simplifying access to models like AlphaFold and GROMACS, Tamarind Bio helps teams accelerate drug discovery and focus on innovation.
AI-Powered Materials Discovery
Transforms soft biomaterials R&D by combining robotics, AI, and high-throughput automation. Its platform replaces slow, manual hydrogel testing with reproducible, data-driven workflows that speed up the formulation, characterization, and development of next-generation materials for applications in healthcare, wound care, and drug delivery.
AI-Powered Dental Practice Platform
An AI-native operating system for dental practices, bringing patient communication, scheduling, practice management, and marketing into one integrated platform. Its AI receptionist answers calls and books appointments around the clock, while automated workflows help practices follow up with patients, fill open chair time, generate reviews, and convert more leads into bookings.
Real-Time AI for Sales Calls
Real-time AI intelligence for sales teams, connecting calls, documents, CRM data, and company knowledge into a continuously evolving organizational brain. The platform prepares representatives before meetings, delivers trusted, source-grounded answers during live conversations, and automatically turns every call into structured follow-up, actionable insights, and accurate CRM records.
The Unified Litigation AI Operating System
Autonomous AI Product Studio and Company Brain
An autonomous AI product studio building and scaling consumer apps, enterprise tools, and vertical AI products. Sentez combines experienced builders, a proprietary technology stack, and organic distribution to rapidly turn validated ideas into live products. Its second engine, Qualia, acts as a company brain, connecting knowledge, context, and workflows to help small teams operate at greater scale.
How we
support founders
We partner closely with founders to build disciplined, scalable companies capable of global leadership.
Treeo VC provides
direct exposure
to high-conviction, cross-border
Al-native innovation.
Ecosytem Access
Our LPs gain exposure to an international network of entrepreneurs, technology leaders, and venture investors, creating opportunities for strategic connections, knowledge exchange, and collaboration.
Pipeline Development
Our sourcing combines global founder networks, leading startup ecosystems, and rigorous investment screening to identify promising companies early, with particular attention to technical differentiation, commercial validation, and execution capabilities.